Specialty Sales Representative - Cardiometabolic Rare Disease

Scorpion Therapeutics; New York (NY); On-site; USD 90,000 - 130,000; Full time

Job summary

Scorpion Therapeutics is seeking a Specialty Sales Representative to launch and expand Arrowhead's cardiometabolic RNAi therapies, focusing on Plozasiran for conditions like FCS and SHTG. You will develop data-driven territory plans, activate prescribers through clinical education, and manage relationships within complex healthcare environments.

The role requires 5+ years of pharma sales experience (3+ in specialty/rare disease or cardiovascular areas) and a proven track record launching complex

Qualifications

• Bachelor's degree or equivalent.
• 5+ years pharma sales experience, with 3+ years in specialty, rare disease, or cardiovascular areas.
• Proven success launching complex therapies.
• Strong clinical and strategic skills.

Responsibilities

• Develop data-driven territory plans.
• Drive prescriber activation through clinical education.
• Manage stakeholder relationships within complex healthcare systems.
• Collaborate with cross-functional teams to support market growth; ensure compliance and manage field activities with ~30% travel.

Skills

Pharma sales

Clinical knowledge

Strategic planning

Stakeholder management

Cross-functional collaboration

Education

Bachelor's degree or equivalent

Job description

Role: Specialty Sales Representative focused on launching and expanding Arrowhead's cardiometabolic RNAi therapies, particularly Plozasiran for conditions like FCS and SHTG.

Responsibilities

• develop data-driven territory plans
• drive prescriber activation through clinical education
• manage stakeholder relationships within complex healthcare systems
• collaborate with cross-functional teams to support market growth; also ensure compliance and manage field activities with ~30% travel.

Requirements

• Bachelor's degree or equivalent
• minimum 5 years pharma sales experience, with 3+ years in specialty, rare disease, or cardiovascular areas
• success in launching complex therapies
• strong clinical and strategic skills

Preferred

• experience navigating IDNs and complex healthcare environments.

High-Value

• focus on RNAi therapeutics, cardiometabolic indications, specialty and rare disease markets, Phase 3 or pre-approval pipeline, and cross-functional engagement in a fast-paced launch context.